P23: Elvitegravir/cobicistat/emtricitabine/tenofovir DF demonstrates durable efficacy and safety versus efavirenz/emtricitabine/tenofovir DF at Week 144
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI